Recruitment and Training of Personnel and Expansion of the Sales and Development Structure
First written in FY2016. 2 of 9 entries say "Restated". Latest entry: FY2025.
2 other companies' latest entry also says "Other".
- FY2025Increase in group personnelAnnual report
「As of 30 September 2025: Segment name: Medical and Nursing Care Cloud Platform Business, 83; Healthy Life Expectancy Extension Business, 154; Solution Development Business, 73; Total, 310」
Consolidated employees totaled 310, allocated across the medical and nursing care cloud, healthy life expectancy extension and solution development businesses. - FY2024-Q1Effect of increased headcount at headquartersAnnual report
「Temporary costs increased due to new store openings and an increase in headquarters personnel aimed at expanding the scale of future operations, resulting in a segment loss of ¥7.995 million, compared with a segment loss of ¥1.977 million in the same period of the previous year.」
New store openings and an increase in headquarters personnel associated with the expansion of the Healthy Life Expectancy Extension business were reflected as higher temporary costs. - FY2023Expansion of group headcountAnnual report
「The main reasons for the 105-person increase in the number of employees from the end of the previous consolidated fiscal year were the increase in staff accompanying the opening of new stores by Urban Fit Co., Ltd. and the consolidation of Ruby Development Co., Ltd. as a consolidated subsidiary from the current consolidated fiscal year.」
The increase of 105 in group employees from the end of the previous consolidated fiscal year to 286 was attributed to new store openings by Urban Fit and the consolidation of Ruby Development. - FY2022-Q3Effect of increased headcount and M&A expensesAnnual report
「Selling, general and administrative expenses increased by ¥108.815 million from the same period of the previous year to ¥797.292 million, mainly due to higher personnel expenses associated with increased headcount to address rising demand and ¥31.000 million in incidental expenses related to the acquisition of shares in an affiliated company in connection with an M&A transaction.」
In addition to the increased headcount to address rising demand, ¥31.000 million in M&A-related incidental expenses was incurred, resulting in a ¥108.815 million year-on-year increase in selling, general and administrative expenses. - FY2022-Q2Effect of increased headcountAnnual report
「Selling, general and administrative expenses increased by ¥45.290 million from the same period of the previous year to ¥502.729 million, mainly due to higher personnel expenses associated with increased headcount to address rising demand.」
The company increased its headcount to address rising demand, resulting in a ¥45.290 million year-on-year increase in selling, general and administrative expenses, mainly due to higher personnel expenses. - FY2022-Q1Effect of increased headcountAnnual report
「Research and development expenses decreased following the completion of the joint research period with Asahikawa Medical University, while selling, general and administrative expenses increased by ¥20.348 million from the same period of the previous year to ¥252.021 million, mainly due to higher personnel expenses associated with the increase in headcount.」
Higher personnel expenses associated with the increase in headcount were reflected in selling, general and administrative expenses, which increased by ¥20.348 million year on year. - FY2021RestatedAnnual report
「The group believes that recruiting and developing talented personnel is essential for sustained growth. In particular, markets related to an aging society are continuing to expand and generating numerous business opportunities, making it necessary to secure the personnel required for sales and support operations associated with opening new sales offices in response to these opportunities.」
The company is reaffirming its policy of recruiting and developing personnel for sales, support and development to address regulatory and institutional changes. - FY2018RestatedAnnual report
「Accordingly, the company will focus on recruiting and developing the personnel it needs.」
The company has reaffirmed its policy of continuing to recruit and develop personnel needed to establish sales offices and develop systems in response to regulatory reforms. - FY2016First statedAnnual report
「Accordingly, the company will focus on recruiting and developing the personnel it needs.」
The company’s policy is to recruit and develop personnel needed to establish sales offices and develop systems in response to regulatory reforms.